Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time

Size: px
Start display at page:

Download "Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time"

Transcription

1 April 27, 2018 Company Sponsored Research Morning Meeting Note Lower Price Target; Lower Earnings Estimates Socket Mobile, Inc. (SCKT) Equity Research Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time E 2019E OLD NEW OLD NEW OLD NEW Mar. $0.09 $0.05 $0.07 ($0.03)A $0.09 ($0.01) June Sep Dec (0.39) EPS $1.80 ($0.20) $0.29 $0.20 $0.37 $0.28 P/E 14.5x 10.4x Note: NR = Not Rated. Risk Ratings: H = Highly risky; M = Moderately risky GAAP EPS include $1.45 in one-time tax benefits, 2017 GAAP EPS include $0.36 one-time tax charge. GAAP EPS are based on a statutory tax rate of 42% in 2017 and 28% annually in Pro forma EPS assume a 5% cash tax rate in and a 15% rate in Sum of quarterly data may not equal full-year data due to rounding and/or changes in share count. NC = Not covered by. *EPS including amortization expense. Year E 2019E Rev.(Mil.) $13.5 $17.5 $13.6 $15.7 $17.0 $18.4 $20.8 $21.3 $20.4 $21.9 GAAP EPS ($1.05) ($0.56) ($0.68) ($0.13) $0.08 $0.31 $1.80 ($0.20) $0.20 $0.28 Description: Socket Mobile, Inc. ( offers wireless barcode scanners that connect to mobile devices over Bluetooth. Options include 1D, Laser, and 2D scanning engines, as well as IP54-rated durable for industrial use. Software supports integration to point of sale (POS) or other data capture applications. Headquarters are in Newark, CA. SCKT reported a 1Q:18 GAAP per share loss of $0.03 (adjusted loss of $0.04) on revenue of $4.0 million, which compared with our estimates for GAAP EPS of $0.07 (adjusted $0.09) on $5.6 million revenue. Revenue was hampered by several factors including a product delay, slower enterprise deployment activity, and slowing growth from U.S. retail point of sale. The product shipping delays were resolved in April, and we think impact on 2Q:18 should be minimal; however, slower demand prompts us to adjust our revenue growth estimates to a decline of 4.4% in 2018 and a gain of 7.6% in 2019, versus the roughly 10% growth rate we previously expected in both periods. Still, the company made strides with a more efficient product design that should support a pickup in growth over a longer-term period and allow quicker product refreshes. We think SCKT remains well ahead of competitors. We reduce our EPS estimates to $0.20 (from $0.29) in 2018 and $0.28 (from $0.37) in 2019, taking into account lower growth from the run rate scanner business and lower contribution from the corporate deployment business. We lower our price target to $4 (from $6), which is based on 12x our revised 2019 adjusted EPS estimate of $0.36. (Our previous $6 target was based on 13x our prior 2019 EPS estimate of $0.49.) This multiple is in line with our five-year EPS CAGR projection. Matthew Galinko (212) (mgalinko@sidoti.com) Key Statistics NR Price Target: $4 Price: $2.90 Risk Rating: M Analysts Covering 1 Market Cap (Mil) $20 Enterprise Value $15 52-Week Range (NASDAQ) Year EPS CAGR 12% Avg. Daily Trading Volume 60,000 Shares Out (Mil) Float Shares (Mil) Insider Ownership 19% Institutional Holdings 8% Annualized Dividend Dividend Yield Nil N/A FCF Per Share (2019E) $0.22 FCF Yield (2019E) 7.6% Net Cash Per Share (2019E) $0.31 Price to Book Value 1.2x Return on Equity (2019E) 11.0% Total Debt to Capital Nil Interest Coverage Ratio 30.4x Short Interest % 1.2% Short Interest Days To Cover 3.4 Russell ,562 Russell 2000 Last 12 Months 12.4% SCKT Last 12 Months -32.4% SCKT reported a weak start to 2018 demand for barcode scanners. Transient pressure from a product flaw in a new product line discovered just before shipment to distributors weighed on orders in 1Q:18. The flaw was repaired and product launch completed earlier this week. However, management discussed less activity around corporate scanner deployments, which accounted for about $2.2 million in annual revenue on average over the past two years. We see no specific reason for the slowdown in pipeline and think that a recovery is likely over time, particularly as SCKT launches new and improved products. In addition to weakness in corporate deployments, the revenue generated as a result of application partner sales has struggled under shifting partner priorities (from new customer Required disclosures appear in the Appendix Member FINRA & SIPC 1212 Avenue of the Americas 15 th Floor New York, NY Phone:

2 SOCKET MOBILE, INC. acquisition to customer retention). Near-term pressure on the business prompts us to reduce our revenue and earnings estimates. However, we think the outlook is significantly better than results over the past two quarters. Revenue from markets beyond the mobile point of sale is growing rapidly, although still small in the mix. Furthermore, international expansion for mobile point of sale could begin to make up for slower U.S. growth over time. SCKT s investment in product enhancements and software tools to ease the implementation of advanced scanner features could entice the current install base to purchase new, higher priced scanners, as well as lead more new customers to a higher price scanner from their initial purchase. In other words, when application partners were in rapid customer growth mode, SCKT benefitted from the wave. Now, although SCKT does not directly own the customer relationship, it is rolling out features that make it easier for the application developer and end user to use more advanced features that may induce a replacement or additional barcode scanner sale. SCKT invests significantly in R&D and is becoming more flexible and responsive to customer and end market demands, which we think will serve the company over the long run. We continue to see SCKT s scale in the mobile barcode scanner market as a benefit that likely prevents new competitors from gaining traction. Lastly, management noted that the low interest in corporate deployment of scanners does not follow a cyclical or historical pattern; it also does not reflect competitive losses as no business is being floated to compete for. We think this topic is subject to further exploration, and note that for now, our estimates do not include corporate deployments. We lower our price target to $4 (from 6) on Socket Mobile. We obtain our target by applying a 12x multiple to our revised 2019 adjusted EPS estimate of $0.36. (Our previous $6 target was based on 13x our prior 2019 EPS estimate of $0.49.) We lower the multiple to account for the slower projected revenue growth. We think this multiple is a fair reflection of the strength of the core strategy despite near-term challenges. SCKT shares have retreated from the 52-week high of $4.59 each and stock tender price of $3.90. Projected growth in the core barcode scanner business effectively accounts for all of our revenue projections in 2018 and 2019, and we think strong customer uptake of refreshed products, international expansion, and a return of enterprise revenue could produce revenue gains beyond our estimates. We caution that with more than 96% of revenue generated from barcode scanner sales, market weakness or significantly increased competition could diminish the company s results and the stock s valuation. Also note that about 20% of scanner revenue is historically generated by large corporate deployments, with most of the remainder from first-time scanner buyers, presumably small retailers. Large deployments are difficult to predict, prone to volatility, and likely subject to greater competition, compared with the core business, in our view. Key Risks End-market demand Elevated competition Timing of large orders Exhibit 1: SCKT 1Q:18 Variance Chart ($ in millions, except per share amounts) 1Q:18E 1Q:18A Variance 1Q:17A $ Change Y/Y% Change Revenue $5.6 $4.0 ($1.6) $5.6 ($1.6) -29.2% Gross Profit $3.0 $2.1 ($0.9) $2.9 ($0.8) -29.1% Gross Margin 53.6% 51.8% 51.8% Operating Income $0.8 ($0.3) NM $0.7 NM NM Operating Margin 14.3% -7.2% 11.9% Net Income $0.7 ($0.3) NM $0.6 NM NM Net Margin 12.5% -6.3% 10.8% GAAP EPS $0.07 ($0.03) ($0.10) $0.05 ($0.08) NM Adjusted EPS $0.09 ($0.04) ($0.13) $0.08 NM NM Source: Company reports and estimates. 2

3 Table 1: Socket Mobile Inc. Income Statement ($ in millions, except per share data) SOCKET MOBILE, INC. Mar June Sept Dec 2016 Mar June Sept Dec 2017 MarA JuneE SeptE DecE 2018E March June Sept Dec 2019E Revenue $5.0 $5.2 $5.1 $5.4 $20.8 $5.6 $5.8 $5.5 $4.4 $21.3 $4.0 $5.8 $5.7 $4.8 $20.4 $4.2 $6.1 $6.3 $5.3 $21.9 Cost of revenue Gross profit Research and development Sales and marketing General and administrative Total operating expenses Operating income (0.3) (0.0) EBITDA (0.2) Interest expense and other (0.0) (0.1) (0.1) (0.1) (0.2) Net income before taxes (0.3) (0.0) Provision for income tax (9.8) (9.7) (0.1) (0.0) Net income (2.7) (1.5) (0.2) (0.0) Adjusted net income (0.1) 2.1 (0.3) (0.0) GAAP EPS basic $0.10 $0.09 $0.11 $1.78 $2.10 $0.07 $0.08 $0.07 ($0.39) ($0.23) ($0.03) $0.10 $0.10 $0.04 $0.20 ($0.01) $0.10 $0.11 $0.07 $0.28 GAAP EPS diluted $0.09 $0.07 $0.10 $1.40 $1.80 $0.05 $0.07 $0.06 ($0.39) ($0.20) ($0.03) $0.10 $0.10 $0.04 $0.20 ($0.01) $0.10 $0.11 $0.07 $0.28 Adjusted EPS diluted $0.08 $0.07 $0.10 $0.08 $0.34 $0.08 $0.11 $0.10 ($0.01) $0.28 ($0.04) $0.13 $0.13 $0.05 $0.26 ($0.01) $0.14 $0.14 $0.09 $0.36 Basic shares outstanding Diluted shares outstanding % yoy change Revenue 25.9% 16.2% 12.9% 0.7% 13.0% 11.5% 11.4% 7.3% -19.3% 2.4% -29.2% 0.0% 5.0% 10.0% -4.4% 5.0% 5.0% 10.0% 10.0% 7.6% Gross profit 38.6% 22.0% 17.5% -2.0% 16.8% 16.2% 20.5% 15.8% -14.6% 9.2% -29.1% -1.1% 0.0% 10.1% -5.7% 7.3% 5.0% 10.0% 10.0% 8.1% R&D 14.3% 34.7% 22.2% 26.7% 24.4% 21.3% 15.9% 24.1% 19.9% 20.2% 18.8% 1.4% -1.3% -3.0% 3.5% -11.7% 5.0% 10.0% -7.4% -1.4% S&M 11.1% 12.1% 13.8% 7.7% 11.1% 10.5% 8.6% 6.2% 0.6% 6.4% -2.8% 5.7% 5.3% 1.1% 2.3% 2.0% 2.7% 7.6% 2.7% 3.7% G&A -6.8% 23.6% 13.8% 19.1% 11.1% 22.6% 4.3% 28.6% 7.4% 15.4% -3.6% 10.1% 0.2% 9.2% 3.6% 0.7% 1.3% 5.2% -2.2% 1.3% Op Ex 6.1% 23.0% 16.8% 17.5% 15.6% 17.8% 10.1% 18.8% 9.8% 14.0% 4.6% 5.2% 1.3% 1.6% 3.1% -3.9% 3.2% 7.8% -2.7% 1.1% Operating income NM 18.5% 19.5% -35.2% 20.4% 11.3% 56.8% 7.9% -90.1% -5.7% % -16.2% -3.6% NM -38.4% -85.3% 10.6% 16.8% 120.0% 51.6% EBITDA NM 20.3% 22.2% -31.8% 22.1% 12.4% 52.5% 7.2% -80.4% -3.9% % -14.8% -2.8% NM -35.1% % 10.1% 16.1% 97.7% 44.5% EBT NM 34.3% 28.2% -34.1% 31.5% 14.7% 58.5% 9.4% NM -5.0% % -7.0% 5.7% NM -28.2% -84.2% 3.8% 9.4% 85.1% 36.0% Net income NM 28.9% 22.6% NM NM -29.6% -6.4% -38.1% NM NM % 20.6% 38.7% NM NM -83.7% 3.8% 9.4% 85.1% 35.4% Adjusted net income NM 28.9% 24.4% -36.8% 28.2% 10.6% 60.1% 7.1% NM -12.3% % -7.0% 5.7% NM -23.2% -84.2% 3.8% 9.4% 85.1% 36.0% Adjusted EPS NM 4.8% 7.5% -45.9% 11.7% -7.4% 49.4% 4.0% NM -19.4% % 26.2% 30.9% NM -5.1% -81.7% 1.7% 6.8% 79.8% 38.9% % of revenue Gross margin 49.7% 49.5% 51.5% 50.1% 50.2% 51.8% 53.6% 55.6% 53.0% 53.5% 51.8% 53.0% 53.0% 53.0% 52.8% 53.0% 53.0% 53.0% 53.0% 53.0% R&D 13.0% 14.2% 13.8% 14.5% 13.9% 14.2% 14.8% 16.0% 21.5% 16.3% 23.8% 15.0% 15.0% 19.0% 17.7% 20.0% 15.0% 15.0% 16.0% 16.2% S&M 13.6% 13.1% 13.6% 13.1% 13.3% 13.5% 12.8% 13.5% 16.3% 13.9% 18.5% 13.5% 13.5% 15.0% 14.8% 18.0% 13.2% 13.2% 14.0% 14.3% G&A 11.1% 11.1% 10.1% 10.2% 10.6% 12.3% 10.4% 12.1% 13.6% 12.0% 16.7% 11.4% 11.5% 13.5% 13.0% 16.0% 11.0% 11.0% 12.0% 12.2% Op Ex 37.8% 38.4% 37.5% 37.8% 37.9% 39.9% 37.9% 41.5% 51.4% 42.2% 59.0% 39.9% 40.0% 47.5% 45.5% 54.0% 39.2% 39.2% 42.0% 42.7% Op Income 11.9% 11.1% 14.1% 12.3% 12.3% 11.9% 15.6% 14.2% 1.5% 11.4% -7.2% 13.1% 13.0% 5.5% 7.3% -1.0% 13.8% 13.8% 11.0% 10.3% EBITDA 13.2% 12.4% 15.6% 13.5% 13.7% 13.3% 17.0% 15.6% 3.3% 12.8% -5.8% 14.5% 14.4% 6.9% 8.7% 0.4% 15.2% 15.2% 12.4% 11.7% Adjusted net income 1.7% 1.4% 1.9% 1.5% 1.6% 1.4% 1.8% 1.8% -0.3% 1.3% -0.9% 2.3% 2.3% 1.1% 1.3% -0.2% 2.2% 2.2% 1.8% 1.7% Sources: Company reports and estimates 3

4 SOCKET MOBILE, INC. Table 2: Socket Mobile Inc. Cash Flow Statement ($ in millions, except per share data) 2015 March June Sept Dec 2016 Mar June Sept Dec E 2019E Net income $1.8 $0.5 $0.5 $0.7 $10.7 $12.4 $0.4 $0.5 $0.4 ($2.7) ($1.4) $1.2 $1.6 Stock-based compensation Depreciation Changes in deferred taxes (10.0) (10.0) Accounts receivable (0.5) (0.0) (0.1) (0.2) 0.1 (0.2) (0.5) 0.3 (0.3) (0.4) (0.6) Inventory (0.4) (0.2) 0.6 (0.3) (0.4) (0.2) (0.3) (0.4) (0.0) 0.0 (0.7) 0.7 (0.2) Prepaid expenses and other current 0.0 (0.0) (0.1) (0.0) 0.0 (0.1) (0.1) (0.2) (0.1) (0.4) (0.5) Other assets (0.0) (0.0) (0.0) Accounts payable and accrued expenses (0.8) 0.1 (0.7) (0.0) (0.4) (1.0) 0.4 (0.4) (0.0) (0.1) (0.1) (0.1) 0.1 Accrued payroll and related expenses 0.1 (0.0) (0.1) (0.0) (0.0) (0.1) 0.0 Customer deposit 0.6 (0.3) 0.5 (0.8) (0.8) (1.5) (0.1) Net deferred revenue on shipments to distributors 0.0 (0.1) (0.6) (0.0) 0.1 (0.0) 0.1 (0.1) 0.0 Deferred service revenue (0.1) (0.0) (0.0) (0.0) (0.0) (0.1) (0.0) 0.0 (0.0) (0.0) (0.0) (0.1) 0.0 Change in deferred rent (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.3) 0.0 Net cash provided by operating activities Purchase of equipment (0.4) (0.1) (0.0) (0.1) (0.1) (0.3) (0.1) (0.0) (0.1) (0.2) (0.4) (0.3) (0.3) Capitalized software costs (0.2) (0.2) Net cash provided by investing activities (0.4) (0.1) (0.0) (0.1) (0.1) (0.3) (0.1) (0.0) (0.1) (0.4) (0.6) (0.3) (0.3) Payments on capital leases (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.1) (0.4) Proceeds from borrowing under bank line of credit agreement (2.0) Repayments of borrowing under bank line of credit agreement (1.0) (0.5) (0.4) Proceeds from term loan Payment on term loan (3.0) (0.8) Repurchase of common stock (4.0) 0.0 Stock options exercised Warrants exercised Repayment of related party and short-term credit line payable (0.1) 0.0 (0.5) (0.5) Net cash provided by financing activities (0.7) 0.1 (0.3) (0.0) 0.1 (0.2) (1.1) (3.2) Net increase in cash and equivalents (1.5) Cash and equivalents, beginning of period Cash and equivalents, end of period FCF FCF/share $0.16 $0.01 $0.04 $0.01 $0.01 $0.07 $0.02 $0.06 $0.09 $0.10 $0.26 $0.22 $0.29 FCF less share-based compensation (SBC) 0.8 (0.0) (0.1) FCF less SBC / share $0.13 ($0.00) $0.03 $0.00 ($0.01) $0.02 $0.01 $0.04 $0.08 $0.08 $0.21 $0.16 $0.22 Sources: Company reports and estimates 4

5 Table 3: Socket Mobile Inc. Balance Sheet ($ in millions, except per share data) SOCKET MOBILE, INC. Mar June Sept 2016 Mar June Sept E 2019E Cash and equivalents $1.0 $1.1 $1.1 $1.3 $1.6 $2.1 $2.9 $3.4 $3.6 $2.1 Accounts receivable Inventory Prepaid expenses and other Total current assets Property and equipment Machinery and office equipment Computer equipment Accumulated depreciation Goodwill Other assets Deferred tax assets Total assets Accounts payable and accrued expenses Accrued payroll and related expenses Net deferred revenue on shipments to distributors Customer deposits Related party and other short-term credit line notes payable Related party convertible payable Short-term portion of deferred service revenue Total current liabilities Related party convertible note payable Term loan Long-term portion of capital leases and deferred rent Deferred tax liability Total liabilities Total stockholders' equity Total liabilities and stockholders' equity DSO Inventory days Total debt to capital 19.9% 12.4% 16.3% 6.3% 5.8% 5.5% 1.4% 1.6% 0.0% 0.0% Net cash (debt) ($0.0) $0.4 $0.1 $0.2 $0.6 $1.1 $2.9 $3.1 $0.6 $1.9 Net cash (debt) per share ($0.00) $0.05 $0.01 $0.03 $0.07 $0.14 $0.40 $0.44 $0.11 $0.31 Return on equity NM NM NM NM NM NM 92.2% NM 7.6% 11.0% Sources: Company reports and estimates 5

6 Appendix Required Disclosures Required Disclosures Socket Mobile, Inc. (SCKT-$2.90) NR Price Target: $4 Risk Rating: M Rating and Price Target History Table Action Date Px Rating PT Risk Rating Initiation 9/7/ NR 0 M Key Risks End-market demand Elevated competition Timing of large orders Valuation: We lower our price target to $4 (from 6) on Socket Mobile. We obtain our target by applying a 12x multiple to our revised 2019 adjusted EPS estimate of $0.36. (Our previous $6 target was based on 13x our prior 2019 EPS estimate of $0.49.) We lower the multiple to account for the slower projected revenue growth. We think this multiple is a fair reflection of the strength of the core strategy despite near-term challenges. SCKT shares have retreated from the 52-week high of $4.59 each and stock tender price of $3.90. Projected growth in the core barcode scanner business effectively accounts for all of our revenue projections in 2018 and 2019, and we think strong customer uptake of refreshed products, international expansion, and a return of enterprise revenue could produce revenue gains beyond our estimates. We caution that with more than 96% of revenue generated from barcode scanner sales, market weakness or significantly increased competition could diminish the company s results and the stock s valuation. Also note that about 20% of scanner revenue is historically generated by large corporate deployments, with most of the remainder from first-time scanner buyers, presumably small retailers. Large deployments are difficult to predict, prone to volatility, and likely subject to greater competition, compared with the core business, in our view. Sidoti & Company. is a licensed broker/dealer, and publishes research reports about some of the securities it follows. All research published by is based on public information, or on information from the company discussed in the report that that company is required to promptly make public. This report was prepared for market professionals and institutional investor customers. Market professionals and institutional investors should consider this report as only one factor in making their investment decisions. This report is for information purposes only and is not intended as an offer to sell or a solicitation to buy securities. This research report is not a substitute for the exercise of your independent judgment. Information contained herein is based on sources we believe to be reliable but we do not guarantee their accuracy. The stock rating on this report reflects the analyst s recommendation based on a 12-month period. It should be presumed that the analyst who authored this report has had discussions with the subject company to ensure factual accuracy prior to publication. Sidoti does NOT own securities of the issuers described herein, and Sidoti does not make a market in any securities. Sidoti does not engage in, or receive compensation from, any investment banking or corporate finance-related activities with the company discussed in the report. Sidoti s contracts with issuers protect Sidoti s full editorial control of all research, timing of release of reports, and release from liability for negative reports. To ensure further independence, the company discussed in the report has agreed to a minimum coverage term of one Initiation Report and three Update Reports, which that company cannot unilaterally terminate earlier. takes steps to ensure analyst independence including setting fees in advance and utilizing analysts who must abide by the CFA Institute Code of Ethics and Standards of Professional Conduct. Each Sidoti & Company, LLC analyst has full discretion on the rating and revenue target based on his or her own due diligence. Analysts are paid in part based on overall profitability of. Such profitability is derived from a variety of sources and includes payments received from issuers of securities covered by for services described below. No part 6

7 APPENDIX CONTINUED of analyst compensation was, or will be, directly or indirectly, related to the specific recommendations or views expressed in any report or article. All issuers to be considered for research obtain the approval of a stock selection committee comprised of the Director of Research, the Chief Compliance Officer, and an independent outside person for screening applicants. Sidoti Company Sponsored Research Rating System The Company Sponsored Research rating system consists of Moderately Risky (M) and Highly Risky (H) ratings. Moderately Risky suggests companies, that while still subject to relatively high price volatility, are characterized by more stable and predictable cash flow, a more established operating history, and an operating environment that is somewhat less competitive with a potential for loss of principal. Highly Risky suggests high risk equities of companies with a short or unprofitable operating history, limited or less predictable revenues, very high risk associated with success, significant financial or legal issues, or a substantial risk/loss of principal. As of 04/27/18, Company Sponsored Research Cap Research provides research on 13 companies, of which 8 (61%) are rated Moderately Risky and 5 (38%) are rated Highly Risky. Earnings targets and opinions concerning the composition of market sectors included in this report reflect analyst judgments as of this date and are subject to change without notice. A risk to our earnings targets is that the analyst s estimates or forecasts may not be met. This report contains forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from such forward-looking statements. Factors that may cause such differences include, but are not limited to, those discussed in the Risk Factors section in the issuer s SEC filings available in electronic format through SEC Edgar filings at Every company in the Microcap sector bears certain inherent risks and will not provide any company subject to those risks with a rating below moderate because stock in the Microcap segment of the market have many risks that are not as prevalent in Large-Cap, Blue Chips, or even Small-Cap stocks. Often it is these risks that cause Microcap stocks to trade at discounts to their peers. The most common of these risks is liquidity risk, which is typically caused by small trading floats and very low trading volume which can lead to large spreads and high volatility in stock price. In addition, Microcaps tend to have significant company specific risks that contribute to lower valuations. Investors need to be aware of the higher probability of financial default and higher degree of financial distress inherent in the Microcap segment of the market. Sidoti & Company policy is to update research reports as and when the Research Analyst and Research Management deem appropriate, based on developments with the issuer, the sector, or the market that may have a material impact on the research views or opinions stated therein. In addition, certain Research publications are intended to be updated on a regular periodic basis (weekly/monthly/quarterly/annual) and will ordinarily be updated with that frequency, unless the Research Analyst and Research Management determine that a different publication schedule is appropriate based on current conditions. Sidoti & Company Research does not provide individually tailored investment advice. Sidoti & Company Research has been prepared without regard to the circumstances and objectives of those who receive it. Sidoti & Company recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. The appropriateness of an investment or strategy will depend on an investor's circumstances and objectives. The securities, instruments, or strategies discussed in Sidoti & Company Research may not be suitable for all investors, and certain investors may not be eligible to purchase or participate in some or all of them. Sidoti & Company Research is not an offer to buy or sell or the solicitation of an offer to buy or sell any security/instrument or to participate in any particular trading strategy. The value of and income from your investments may vary because of changes in interest rates, foreign exchange rates, default rates, prepayment rates, securities/instruments prices, market indexes, operational or financial conditions of companies or other factors. There may be time limitations on the exercise of options or other rights in securities/instruments transactions. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realized. If provided, and unless otherwise stated, the closing price on the cover page is that of the primary exchange for the subject company's securities/instruments. These opinions may not fit to your financial status, risk and return preferences. For this reason, to make an investment decision by relying solely to this information stated here may not bring about outcomes that fit your expectations. The trademarks and service marks contained in Sidoti & Company Research are the property of their respective owners. Third-party data providers make no warranties or representations relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability for any damages relating to such data. Investors should consider Sidoti & Company Research as only a single factor in making their investment decision. For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada Alternatively you may contact your investment representative or Sidoti & Company Research at 1212 Avenue of the Americas, (Attention: Director of Research), New York, NY USA. Compensation. received a flat fee of $40,000, renewable annually from the company discussed in this report for the creation and dissemination of an Initiation Report and three Update Reports, including this report. The purpose of the fee is to subsidize the high costs of research and monitoring. Sidoti holds a conference twice a year and charges a fee of $5,000 per conference for presenting companies. This fee was waived for the participation in one conference. Sidoti does not currently have a current investment banking services relationship with the company discussed in this report, or contemporaneously with any other companies discussed in other (Sidoti) Company Sponsored Research reports. Sidoti has not received investment banking income from the company discussed in the report in the past 12 months, and does not expect to 7

8 APPENDIX CONTINUED receive investment banking income from the company discussed in the report in the next 12 months. Of securities rated in other Sidoti Company Sponsored Research reports, Sidoti has received investment banking income from 0 companies (0%) in the past 12 months. Investment banking services, as defined under FINRA Rule 2241, include, among other things, acting as an underwriter in, or as a member of the selling group in, a securities underwriting. Sidoti s role in any issuer s investment banking transaction can be viewed in that issuer s filings at Sidoti has non-research employees who will seek compensation for brokerage commission revenue in connection with market trading the securities of this company. has received compensation for non-investment banking services on the Small-Cap Universe, and expects to receive additional compensation for non-investment banking services on the Small- Cap Universe, paid by issuers of securities covered by analysts. These non-investment banking services include investor relations services and software, financial database analysis, advertising services, brokerage services, advisory services, investment research, investment management, non-deal road shows, and attendance fees for conferences sponsored or co-sponsored by. Sidoti Analysts. The research analyst certifies that this report accurately reflects his/her personal views about the subject securities and issuers and that none of the research analyst's compensation was, is or will be, directly or indirectly, related to the analyst's specific recommendations or views contained in this research report. Sidoti policy does not allow an analyst or a member of their household (i) to own, trade, or have any beneficial interest in any securities of any company that analyst covers, or (ii) serve as an officer or director of a covered company. Sidoti employees, including research analysts, receive compensation that is based in part upon the overall performance of the firm, including revenues generated by Sidoti s investment banking and brokerage activities, but compensation is not directly related to investment banking or brokerage revenues. Sidoti maintains and enforces written policies and procedures reasonably designed to prevent any controlling persons, officers (or persons performing similar functions), or employees of Sidoti from influencing the activities of research analysts and the content of research reports prepared by the research analyst. Sidoti research analysts seek to have management of their covered companies meet with investors during non-deal road shows. Analysts compensation may be related to their success in scheduling non-deal road shows. This approach could be viewed as presenting potential conflicts of interest. Reprints of reports are prohibited without permission. Additional information is available upon request. For any further questions, please contact the Chief Compliance Officer at Sidoti. Source Key Statistics data is sourced from FactSet Research Systems 8

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC October 27, 2017 Company Sponsored Research Morning Meeting Note Earnings Release Socket Mobile, Inc. (SCKT) Equity Research Maintain $6 Price Target; Robust Demand From Application Developer, Despite

More information

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29 April 19, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview OTC Markets Group Inc. (OTCM) Equity Research Forecast 10% EPS Growth In 1Q:18, Aided By Lower Taxes; View OTCM As Well Positioned

More information

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation July 13, 2018 Company Sponsored Research Morning Meeting Note Raise Price Target Sify Technologies Limited Sponsored ADR (SIFY) Equity Research We Raise Our Price Target To $4 (From $3); Think Strong Outlook

More information

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC September 29, 2017 Company Sponsored Research Morning Meeting Note Raise Price Target; Raise Earnings Estimates OTC Markets Group Inc. (OTCM) Equity Research Raise Target To $30 (From $27) As We Introduce

More information

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus TBD TBD TBD TBD N/A $0.02

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus TBD TBD TBD TBD N/A $0.02 October 9, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview Sify Technologies Limited Sponsored ADR (SIFY) Equity Research Expect 2Q:F19 EPS Will Be Flat Year Over Year On 15% Higher

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC February 28, 2019 Intraday Note Lower Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research 4Q:18 Revenue Beats, But EPS Misses On Soft Gross Margin; Although Backlog Supports Growth,

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC November 1, 2018 Intraday Note Raise Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research Increase 2019 EPS Estimate After This Morning s Solid 3Q:18 Report; 3Q:18 EPS Of $0.27 Beat Our

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC December 16, 2016 Morning Meeting Note Raise Price Target AAON, Inc. (AAON) Equity Research Raise Target To $34 (From $28) On Anticipation Of A Lower Tax Rate; Continue To Forecast Strong Growth In 2017-2018;

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC December 13, 2018 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research In Our View, AAON s Outlook For 2019 Is Positive Based On Backlog, Order Trend And Price/Cost; However, We Are Cautious

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC September 15, 2017 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research We Maintain Our Outlook For Robust Growth For AAON, Following A Peer s Positive Commentary Earlier This Week; Maintain

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.20) Morning Meeting Note NEUTRAL

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$20.47) Intraday Meeting Note NEUTRAL

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$23.39) Morning Meeting Note NEUTRAL

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.55) Morning Meeting Note NEUTRAL

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$27.84) Morning Meeting Note NEUTRAL

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive July 5, 2018 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Medical Transcription

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 7, 2018 Alimera Sciences (ALIM - $1.09) Quarter Mostly in-line, 2019 could Benefit from Repeat Usage ALIM

More information

Research Report Update Investors should consider this report as only a single factor in making their investment decision.

Research Report Update Investors should consider this report as only a single factor in making their investment decision. The Standard of Excellence in the Microcap Market Member: NASD, SIPC Research Report Update Investors should consider this report as only a single factor in making their investment decision. AeroCentury

More information

Medifast, Inc. Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. NYSE: MED

Medifast, Inc. Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. NYSE: MED Medifast, Inc. NYSE: MED Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. Medifast engages in the production, distribution, and sale of weight loss and weight loss

More information

Q2 FY19 Supplemental Earnings Slides. October 29, 2018

Q2 FY19 Supplemental Earnings Slides. October 29, 2018 Q2 FY19 Supplemental Earnings Slides October 29, 2018 Safe Harbor Statement Some of the matters discussed in this presentation contain forward-looking statements regarding the Company s future business

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.80) Iluvien sales continue their slow & steady growth ALIM reported 1Q16 roughly in-line

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 21, 2018 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Legacy Education Alliance, Inc.

More information

Small-Cap Research. Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research November 24, 2015 M. Marin 312-265-9211 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts Current Recommendation

More information

ALPHA SELECT LIST CAS Medical Systems, Inc.

ALPHA SELECT LIST CAS Medical Systems, Inc. A Matt G. Hewitt Senior Research Analyst 612-334-6314 matthew.hewitt@craig-hallum.com Lucas Baranowski Research Analyst 612-334-8224 lucas.baranowski@craig-hallum.com Charlie Eidson, CPA Research Analyst

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 23, 2018 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Legacy Education Alliance, Inc. LEAI:

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.07) Impressive Ex-US Sales Help ALIM Exceed Topline Expectations. ALIM recently announced

More information

LifeVantage Corp. NasdaqCM: LFVN

LifeVantage Corp. NasdaqCM: LFVN LifeVantage Corp. NasdaqCM: LFVN New Products and Valuation Outweigh issues in Japan, reiterate Strong Buy LifeVantage Corp (LFVN) focuses on selling healthy living products through direct selling. They

More information

CalAmp Corp. CAMP - $ NASDAQ Buy

CalAmp Corp. CAMP - $ NASDAQ Buy Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH June 28, 2018 Technology: Communications, Wireless & IoT CalAmp Corp. CAMP

More information

Net Element Inc. (NASDAQ: NETE)

Net Element Inc. (NASDAQ: NETE) NEW YORK SÃO PAULO TORONTO Research Note Inc. (NASDAQ: ) reported developments in both its Netevia platform and Unified Payments subsidiary. intends to improve reveneue generation by extending its Netevia

More information

Small-Cap Research. Net Element Inc. (NETE-NASDAQ) OUTLOOK. NETE: Russian Restructuring Should Reduces Losses SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Net Element Inc. (NETE-NASDAQ) OUTLOOK. NETE: Russian Restructuring Should Reduces Losses SUMMARY DATA ZACKS ESTIMATES Small-Cap Research August 17, 2017 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Net Element Inc. NETE: Russian Restructuring Should Reduces Losses

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive January 23, 2019 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 TowerJazz (TSEM-NASDAQ)

More information

Q2 FY07 Earnings April 25, 2007

Q2 FY07 Earnings April 25, 2007 Q2 FY07 Earnings April 25, 2007 Safe Harbor Before we proceed with our presentation, we would like to point out that the following discussion will contain forward-looking statements from industry consultants,

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research May 15, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Cytori Therapeutics (CYTX - $ 2.32) BARDA Decision is a Major Positive Development Yesterday, CYTX

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 8, 2016 PhaseRx (PZRX - $ 1.08) Positive Preclinical Large Animal Study Results; An Important Step For Demonstrating

More information

Small-Cap Research. TowerJazz (TSEM-NASDAQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. TSEM: 2017 on Track, Capacity Plans Need to Be Addressed By Year End

Small-Cap Research. TowerJazz (TSEM-NASDAQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. TSEM: 2017 on Track, Capacity Plans Need to Be Addressed By Year End Small-Cap Research May 9, 217 Lisa Thompson lthompson@zacks.com www.zacks.com 1 S. Riverside Plaza, Suite 16, Chicago, IL 666 TowerJazz (TSEM-NASDAQ) TSEM: 217 on Track, Capacity Plans Need to Be Addressed

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 16, 2018 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Net Element Inc. (NETE-NASDAQ)

More information

Research Note Investors should consider this report as only a single factor in making their investment decision.

Research Note Investors should consider this report as only a single factor in making their investment decision. Research Note Investors should consider this report as only a single factor in making their investment decision. John Nobile AIRI $1.38 (NYSE MKT) July 28, 2017 2013A 2014A 2015A 2016A Revenues (millions)

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 8, 2018 Viking Therapeutics (VKTX - $13.74) 3Q18: Conference Call Uneventful with Investor Focus on the Design

More information

Small-Cap Research. Akoustis Tech (AKTS-OTCQB) AKTS: FYQ1 Results on Target; Uplisting On Track OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Akoustis Tech (AKTS-OTCQB) AKTS: FYQ1 Results on Target; Uplisting On Track OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research November 29, 216 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 1 S. Riverside Plaza, Chicago, IL 666 Akoustis Tech (AKTS-OTCQB) AKTS: FYQ1 Results on Target; Uplisting

More information

Boxlight Corporation (BOXL)

Boxlight Corporation (BOXL) Company Sponsored Research Update Note 08/24/2018 Boxlight Corporation (BOXL) Strong Quarterly Results with Continued Acquisitions Technology Hunter Diamond, CFA Vivian Zhang (Equity Research Associate)

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.15) Continued Execution, EU Uveitis Potential Approval Imminent We recently spent some

More information

Barco N.V. Cinema Drives Top-Line Beat; Healthcare and Enterprise Behind EBITDA Expansion

Barco N.V. Cinema Drives Top-Line Beat; Healthcare and Enterprise Behind EBITDA Expansion EQUITY RESEARCH COMPANY UPDATE February 10, 2017 Stock Rating: PERFORM 12-18 mo. Price Target NA BAR.BR - BRU 80.49 3-5 Yr. EPS Gr. Rate 3% 52-Wk Range 82.28-54.10 Shares Outstanding 12.5M Float 8.6M Market

More information

ASV HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter)

ASV HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

BTO: Q2/15 Earnings Preview

BTO: Q2/15 Earnings Preview B2Gold Corp. (BTO-T: C$1.69), (BTG-N: US$1.31) August 13, 2015 BUY, High Risk Dundee target: C$2.75 BTO: Q2/15 Earnings Preview Joseph Fazzini, CPA, CA, CFA / (647) 428-8248 jfazzini@dundeecapitalmarkets.com

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 1, 2018 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Revolution Lighting Technologies,

More information

April 22, Second Quarter Fiscal 2015 Earnings

April 22, Second Quarter Fiscal 2015 Earnings April 22, 2015 Second Quarter Fiscal 2015 Earnings Safe harbor This presentation and the conference call it accompanies contain forward-looking statements that are inherently subject to risks and uncertainties,

More information

SodaStream Follow-Up: Very Strong 4Q Results Reflect Broad-Based Growth; Estimates Raised

SodaStream Follow-Up: Very Strong 4Q Results Reflect Broad-Based Growth; Estimates Raised EQUITY RESEARCH COMPANY UPDATE March 1, 2011 Stock Rating: OUTPERFORM 12-18 mo. Price Target $48.00 SODA - NASDAQ $39.68 3-5 Yr. EPS Gr. Rate 30% 52-Wk Range $46.88-$20.00 Shares Outstanding 19.2M Float

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Cytori Therapeutics (CYTX - $ 2.07) Management Updates on Lorem Vascular Partnership and Others This

More information

Arcimoto, Inc. FUV - $ NASDAQ Buy

Arcimoto, Inc. FUV - $ NASDAQ Buy Craig Irwin, (646) 358-1910 cirwin@roth.com Annapoorni C.S, CFA, (646) 616-2791 acs@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH February 15, 2019 Cleantech & Industrial

More information

Sierra Wireless, Inc. SWIR - $ NASDAQ Buy

Sierra Wireless, Inc. SWIR - $ NASDAQ Buy Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH August 03, 2018 Technology: Communications, Wireless & IoT Sierra Wireless,

More information

Financial Guidance Increased for Fiscal 2007

Financial Guidance Increased for Fiscal 2007 FOR IMMEDIATE RELEASE Contact: John Gilbert Vice President of Investor and Industry Analyst Relations 1-(858) 658-4813 (ph) 1-(858) 651-9303 (fax) e-mail: ir@qualcomm.com Announces Record Second Quarter

More information

Research Report- Update

Research Report- Update The Standard of Excellence in the Microcap Market Member: NASD, SIPC Buy Research Report- Update Robert C. Schroeder UFP Technologies, Inc. May 15, 2000 Ticker: UFPT--$2.56 (NASDAQ) FY1997 FY1998 FY1999A

More information

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit EQUITY RESEARCH QUARTERLY UPDATE July 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $300.00 ORLY - NASDAQ $277.51 3-5 Yr. EPS Gr. Rate 18% 52-Wk Range $284.66-$225.12 Shares Outstanding 99.4M

More information

Small-Cap Research. OxySure Systems, Inc. (OXYS-OTCQB) OXYS: Another Strong Quarter As Company Preps for European Market UPDATE SUMMARY DATA

Small-Cap Research. OxySure Systems, Inc. (OXYS-OTCQB) OXYS: Another Strong Quarter As Company Preps for European Market UPDATE SUMMARY DATA Small-Cap Research May 16, 2014 Jason Napodano, CFA David Bautz, PhD 312-265-9421 / jnapodano@zacks.com scr.zacks.com 10 S. Riverside Plaza, Suite 1600, Chicago, IL 60606 OxySure Systems, Inc. OXYS: Another

More information

First Quarter Fiscal 2009 Earnings. January 28, 2009

First Quarter Fiscal 2009 Earnings. January 28, 2009 First Quarter Fiscal 2009 Earnings January 28, 2009 Safe Harbor Before we proceed with our presentation, we would like to point out that the following discussion will contain forward-looking statements

More information

IDEXX Laboratories Announces Third Quarter Results

IDEXX Laboratories Announces Third Quarter Results FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Third Quarter Results Delivers 11% normalized organic revenue growth and $1.05 Adjusted

More information

CEVA Inc. CEVA - $ NASDAQ Buy

CEVA Inc. CEVA - $ NASDAQ Buy Suji Desilva, CFA, (415) 306-5120 sdesilva@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH August 07, 2018 Semiconductors & IT Hardware CEVA Inc. CEVA - $32.55 - NASDAQ

More information

SodaStream Follow-Up: 1Q Results Better Than Expected; Guidance Raised; Wal-Mart!!!

SodaStream Follow-Up: 1Q Results Better Than Expected; Guidance Raised; Wal-Mart!!! EQUITY RESEARCH COMPANY UPDATE May 9, 2012 Stock Rating: OUTPERFORM 12-18 mo. Price Target $55.00 SODA - NASDAQ $36.90 3-5 Yr. EPS Gr. Rate 30% 52-Wk Range $79.72-$27.60 Shares Outstanding 19.9M Float

More information

Three Months Ended September 30, 2015 Revenues $ 16,523 $ 18,675 Increase in revenues year over year 20% 13%

Three Months Ended September 30, 2015 Revenues $ 16,523 $ 18,675 Increase in revenues year over year 20% 13% Exhibit 99.1 Alphabet Announces Third Quarter 2015 Results of Google Revenues of $18.7 billion and revenue growth of 13% year over year; constant currency revenue growth of 21% year over year Substantial

More information

scr.zacks.com 10 S. Riverside Plaza, Chicago, IL (STVI-OTC) OUTLOOK ZACKS ESTIMATES Earnings Per Share

scr.zacks.com 10 S. Riverside Plaza, Chicago, IL (STVI-OTC) OUTLOOK ZACKS ESTIMATES Earnings Per Share Small-Cap Research September 15, 2017 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Snap Interactive (STVI-OTC) STVI: LiveXLive Offer Represents More Than

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report OPKO Health (OPK - $5.51) 2Q18: Different Business Operations Progress Well with Several Readouts of Clinical Developments

More information

Oramed Pharmaceuticals Inc. (ORMP $7.21*)

Oramed Pharmaceuticals Inc. (ORMP $7.21*) Oramed Pharmaceuticals Inc. (ORMP $7.21*) Healthcare: Specialty Pharmaceuticals Buy; $20.00 PT; $104.2M Market Cap Company Update Tuesday, April 17, 2018 Revenue/EPS for 2Q18 in Line/Beat Estimates; Time

More information

Small-Cap Research. Lombard Medical (EVAR-NASDAQ) EVAR: $15M Investment, Additional Positive Outcomes Data OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Lombard Medical (EVAR-NASDAQ) EVAR: $15M Investment, Additional Positive Outcomes Data OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research December 21, 2016 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Lombard Medical (EVAR-NASDAQ) EVAR: $15M Investment, Additional

More information

HSBC USA Inc. Barrier Enhanced Participation Notes

HSBC USA Inc. Barrier Enhanced Participation Notes Filed Pursuant to Rule 433 Registration No. 333-223208 April 25, 2018 FREE WRITING PROSPECTUS (To Prospectus dated February 26, 2018, Prospectus Supplement dated February 26, 2018 and Equity Index Underlying

More information

Madison Avenue Securities, LLC

Madison Avenue Securities, LLC Madison Avenue Securities, LLC Wrap Fee Program Brochure January 12, 2018 This Wrap Fee Program Brochure provides information about the qualifications and business practices of Madison Avenue Securities,

More information

[Please refer to Appendix. Verizon Communications, Inc. (VZ) Competition Weighing on Revenue, but Cash Flow Solid RAISING PRICE TARGET

[Please refer to Appendix. Verizon Communications, Inc. (VZ) Competition Weighing on Revenue, but Cash Flow Solid RAISING PRICE TARGET July 26, 2016 Baird Equity Research Connected Technology Verizon Communications, Inc. (VZ) Competition Weighing on Revenue, but Cash Flow Solid Maintain Neutral rating. This morning, Verizon reported mixed

More information

CFO Commentary on Fourth Quarter and Fiscal Year 2015 Preliminary Financial Results

CFO Commentary on Fourth Quarter and Fiscal Year 2015 Preliminary Financial Results Juniper Networks, Inc. 1133 Innovation Way Sunnyvale, CA 94089 January 27, 2016 CFO Commentary on Fourth Quarter and Fiscal Year 2015 Preliminary Financial Results Related Information The following commentary

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report March 2, 2018 Durect Corporation (DRRX - $1.32) DUR-928 Front and Center Stage in 2018 DRRX reported their 4Q17 last

More information

Q Earnings Key Metrics

Q Earnings Key Metrics Q1 2018 Earnings Key Metrics LPL Financial Holdings Inc. Q1 2018 Earnings May 3, 2018 Member FINRA/SIPC 1 Notice to Investors: Safe Harbor Statement Statements in this presentation regarding LPL Financial

More information

Cummins Inc. Nice Second-Quarter EPS Beat but Not Immune to Second-Half Slowdown. Equity Research Global Industrial Infrastructure Capital Goods

Cummins Inc. Nice Second-Quarter EPS Beat but Not Immune to Second-Half Slowdown. Equity Research Global Industrial Infrastructure Capital Goods Equity Research Global Industrial Infrastructure Capital Goods August 02, 2016 Cummins Inc. Nice Second-Quarter EPS Beat but Not Immune to Second-Half Slowdown Summary/Quick take. Cummins reported a solid

More information

Qualcomm Announces Second Quarter Fiscal 2015 Results Revenues $6.9 billion GAAP EPS $0.63, Non-GAAP EPS $1.40

Qualcomm Announces Second Quarter Fiscal 2015 Results Revenues $6.9 billion GAAP EPS $0.63, Non-GAAP EPS $1.40 FOR IMMEDIATE RELEASE Exhibit 99.1 Qualcomm Contact: Warren Kneeshaw Vice President, Investor Relations Phone: 1-858-658-4813 e-mail: ir@qualcomm.com Qualcomm Announces Second Quarter Fiscal Results Revenues

More information

Analog Devices, Third Quarter, Fiscal Schedule A Revenue and Earnings Summary (Unaudited) (In thousands, except per-share amounts)

Analog Devices, Third Quarter, Fiscal Schedule A Revenue and Earnings Summary (Unaudited) (In thousands, except per-share amounts) Analog Devices, Third Quarter, Fiscal Schedule A Revenue and Earnings Summary (Unaudited) (In thousands, except per-share amounts) Revenue $ 1,433,902 $ 1,147,982 $ 869,591 Year-to-year change 65% 47 %

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.49) Patient Recruitment for Vepoloxamer Pivotal (EPIC) Trial is On-track

More information

Arcimoto, Inc. FUV - $ NASDAQ Buy

Arcimoto, Inc. FUV - $ NASDAQ Buy Craig Irwin, (646) 358-1910 cirwin@roth.com Annapoorni C.S, CFA, (646) 616-2791 acs@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH December 28, 2018 Cleantech & Industrial

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research December 15, 2017 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 icad Inc (ICAD-NASDAQ) ICAD: Study Shows IORT Superior

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.61) 2Q14: EPIC Study On-track and More Details of Other Pipeline Developments

More information

Small-Cap Research. Grupo Tmm Sab (GTMAY-OTC) GTMAY: Third Quarter 2014 Review and Looking Ahead to Mexico s Energy Reforms OUTLOOK SUMMARY DATA

Small-Cap Research. Grupo Tmm Sab (GTMAY-OTC) GTMAY: Third Quarter 2014 Review and Looking Ahead to Mexico s Energy Reforms OUTLOOK SUMMARY DATA Small-Cap Research November 6, 2014 Marla Backer 2312-265-9211 mbacker@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Grupo Tmm Sab (GTMAY-OTC) GTMAY: Third Quarter 2014 Review and Looking

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Emergent BioSolutions (EBS - $34.89) Another Acquisition in EBS s Wheelhouse, 2020 Topline $1B Goal in Sight Yesterday

More information

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Consumer: Automotive Retail AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Maintaining SW: 1) auto retail industry growth outlook remains

More information

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE 9 27 31 A S D 10 2016 4 S N D 14 18 2017 26 2 2018 8 16 22 29 F 5 12 20 26 LIVEXLIVE ED IA O RD (5.81000, 5.974,5.67000,5.77000,+0.01000) Relative Strength Index (45.7825) 5 12 19 26 2 A 9 16 23 30 7 14

More information

Analog Devices, Second Quarter, Fiscal Schedule A Revenue and Earnings Summary (GAAP) (In thousands, except per-share amounts)

Analog Devices, Second Quarter, Fiscal Schedule A Revenue and Earnings Summary (GAAP) (In thousands, except per-share amounts) Analog Devices, Second Quarter, Fiscal Schedule A Revenue and Earnings Summary (GAAP) (In thousands, except per-share amounts) Revenue $ 694,536 $ 628,238 $ 659,250 Year-to-year change 5% 1% -2% Quarter-to-quarter

More information

Qualcomm Announces Third Quarter Fiscal 2009 Results Revenues $2.8 Billion, EPS $0.44 Pro Forma EPS $0.54

Qualcomm Announces Third Quarter Fiscal 2009 Results Revenues $2.8 Billion, EPS $0.44 Pro Forma EPS $0.54 FOR IMMEDIATE RELEASE Qualcomm Contact: John Gilbert Phone: 1-858-658-4813 e-mail: ir@qualcomm.com Qualcomm Announces Third Quarter Fiscal 2009 Results Revenues $2.8 Billion, EPS $0.44 EPS $0.54 Raises

More information

Qualcomm Announces Fourth Quarter and Fiscal 2017 Results Fiscal 2017 Revenues $22.3 billion GAAP EPS $1.65, Non-GAAP EPS $4.28

Qualcomm Announces Fourth Quarter and Fiscal 2017 Results Fiscal 2017 Revenues $22.3 billion GAAP EPS $1.65, Non-GAAP EPS $4.28 FOR IMMEDIATE RELEASE Qualcomm Contact: John Sinnott Vice President, Investor Relations Phone: 1-858-658-4813 e-mail: ir@qualcomm.com Qualcomm Announces Fourth Quarter and Fiscal Results Fiscal Revenues

More information

Stryker Corp. Post-4Q15 Thoughts

Stryker Corp. Post-4Q15 Thoughts EQUITY RESEARCH QUARTERLY UPDATE January 27, 2016 Stock Rating: PERFORM 12-18 mo. Price Target $104.00 SYK - NYSE $96.02 3-5 Yr. EPS Gr. Rate 9% 52-Wk Range $105.34-$86.68 Shares Outstanding 378.4M Float

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report June 1, 2018 Viking Therapeutics (VKTX - $9.99) Outlook of VK2809 in NAFLD Continues to Improve; Increase Our Target

More information

Company Overview. Industry Overview. Financial Performance

Company Overview. Industry Overview. Financial Performance Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 27.80 January 20, 2016 Stock Details BSE code 534623 BSE ID JUPITERIN Face value ( ) 10 No of shares (m) 10 52 week

More information

Worldwide 3G Adoption Drives Record Fiscal Year Financial Results

Worldwide 3G Adoption Drives Record Fiscal Year Financial Results FOR IMMEDIATE RELEASE Qualcomm Contact: John Gilbert Vice President of Investor and Industry Analyst Relations 1-(858) 658-4813 (ph) 1-(858) 651-9303 (fax) e-mail: ir@qualcomm.com Qualcomm Announces Fourth

More information

Stellent, Inc. (STEL - $8.59)

Stellent, Inc. (STEL - $8.59) Richard A. Ryan raryan@feltl.com (612) 492-8841 Enterprise Software August 7, 2006 Financial Summary Rev(mil) 2005 2006 2007E Jun $22.3 $28.6 $32.3A Sep $28.0 $30.1 $33.4E Dec $27.7 $31.7 $34.8E Mar $28.5

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 1, 2018 Lisa Thompson 312-265-9517 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 O2Micro International Ltd

More information

December 31, 2018 % Chg. December 31, 2017 (as adjusted) 1 (as adjusted) 1

December 31, 2018 % Chg. December 31, 2017 (as adjusted) 1 (as adjusted) 1 One Penn Plaza, Suite 2832 New York, NY 10119 www.presidio.com Presidio, Inc. Reports Second Quarter Fiscal 2019 Results Record Quarterly Revenue, up 18.3% year over year Strong Quarterly Growth in GAAP

More information

Rajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer

Rajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer Monday, February 4, 2019 www.evaluateresearch.com Target Price Rs. 900.00 Current Price Rs. 598.00 Upside Potential 50% Market Cap. Shares Outstanding Rs. 176,802 mn US$ 2.47 bn 295.3 mn Free Float (FF

More information

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Zacks Company Report EARNINGS UPDATE Acquisition Integration- Short Term Pain For Long Term Gain

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Zacks Company Report EARNINGS UPDATE Acquisition Integration- Short Term Pain For Long Term Gain Small-Cap Research November 14, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 SMTP Inc. (SMTP-NASDAQ) SMTP: Zacks Company Report EARNINGS UPDATE

More information

Alphabet Inc. GOOGL - NASDAQ Neutral -1

Alphabet Inc. GOOGL - NASDAQ Neutral -1 COMPANY UPDATE / ESTIMATE CHANGE / TARGET CHANGE Key Metrics GOOGL - NASDAQ - as of 10/30/17 $1,033.13 Price Target $1,100 52-Week Range $743.59 - $1,063.62 Diluted Shares Outstanding (mil) 703.5 Market

More information

Qualcomm Announces Fourth Quarter and Fiscal 2008 Results Fiscal 2008 Revenues $11.1 Billion, EPS $1.90 Pro Forma EPS $2.25

Qualcomm Announces Fourth Quarter and Fiscal 2008 Results Fiscal 2008 Revenues $11.1 Billion, EPS $1.90 Pro Forma EPS $2.25 FOR IMMEDIATE RELEASE Qualcomm Contact: John Gilbert Phone: 1-858-658-4813 e-mail: ir@qualcomm.com Qualcomm Announces Fourth Quarter and Fiscal 2008 Results Fiscal 2008 Revenues $11.1 Billion, EPS $1.90

More information

Verizon EQUITY RESEARCH QUARTERLY UPDATE PERFORM. VZ 3Q16 First Look: Mixed Results, Positive Guidance Maintained.

Verizon EQUITY RESEARCH QUARTERLY UPDATE PERFORM. VZ 3Q16 First Look: Mixed Results, Positive Guidance Maintained. EQUITY RESEARCH QUARTERLY UPDATE October 20, 2016 Stock Rating: PERFORM 12-18 mo. Price Target NA VZ - NYSE $50.38 3-5 Yr. EPS Gr. Rate 12% 52-Wk Range $56.95-$43.79 Shares Outstanding 4,085.0M Float 3,758.0M

More information

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and Accelerate Marketing, Cutting Earnings Forecast OUTLOOK

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and Accelerate Marketing, Cutting Earnings Forecast OUTLOOK Small-Cap Research August 5, 2015 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and

More information

November 5, Fourth Quarter and Fiscal 2014 Earnings

November 5, Fourth Quarter and Fiscal 2014 Earnings November 5, 2014 Fourth Quarter and Fiscal 2014 Earnings Safe harbor This presentation and the conference call it accompanies contain forward-looking statements that are inherently subject to risks and

More information

ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data)

ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data) UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data) Revenue $ 1,455.9 $ 1,377.6 $ 1,338.0 $ 2,833.5 $ 2,774.7 Cost of revenue (exclusive of amortization shown below) 900.9

More information